Lexeo partners with Johnson & Johnson on cardiac gene therapy delivery
Go back to Lexeo partners with Johnson & Johnson on cardiac gene therapy delivery| Johnson & Johnson (NYSE: JNJ) | Delayed: 260.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $260.35 | 52 Week High | $126.07 | |||
| Open | $260.35 | 52 Week Low | $94.28 | |||
| Day High | $260.35 | P/E | 54.13 | |||
| Day Low | $260.35 | EPS | $4.81 | |||
| Volume | 3,265 | |||||
| (NASDAQ: LXEO) | Delayed: 4.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.84 | 52 Week High | $ | |||
| Open | $4.84 | 52 Week Low | $ | |||
| Day High | $4.84 | P/E | N/A | |||
| Day Low | $4.84 | EPS | $ | |||
| Volume | 35 | |||||
